Analyst Price Targets — AVTR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:39 pm | — | Evercore ISI | $10.50 | $10.40 | TheFly | Avantor price target raised to $10.50 from $8 at Evercore ISI |
| June 26, 2026 10:24 am | — | Bernstein | $10.50 | $10.08 | TheFly | Avantor resumed with a Market Perform at Bernstein |
| June 24, 2026 8:49 am | — | UBS | $8.00 | $9.43 | TheFly | Avantor price target raised to $8 from $7 at Barclays |
| June 1, 2026 8:05 pm | — | Wolfe Research | $7.00 | $9.19 | TheFly | Avantor assumed with Underperform from Peer Perform at Wolfe Research |
| May 14, 2026 8:24 pm | — | RBC Capital | $9.00 | $7.94 | TheFly | Avantor resumed with a Sector Perform at RBC Capital |
| April 14, 2026 10:41 am | — | Barclays | $7.00 | $8.18 | TheFly | Avantor price target lowered to $7 from $8.50 at Barclays |
| February 13, 2026 3:46 pm | — | Morgan Stanley | $10.00 | $9.39 | TheFly | Avantor price target lowered to $10 from $12 at Morgan Stanley |
| February 12, 2026 2:31 pm | Dan Leonard | UBS | $10.50 | $9.35 | TheFly | Avantor price target lowered to $10.50 from $13 at UBS |
| February 12, 2026 1:20 pm | — | Stifel Nicolaus | $10.00 | $9.25 | TheFly | Avantor price target lowered to $10 from $12 at Stifel |
| February 12, 2026 1:09 pm | Tycho Peterson | Jefferies | $8.00 | $9.25 | TheFly | Avantor price target lowered to $8 from $9 at Jefferies |
Latest News for AVTR
Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion of a collaboration between its NuSil® brand, a premier global manufacturer of high-purity silicones suitable for use in medical devices and drug-device combination products, and the Population…
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVTR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.